PRE 14A

PRELIMINARY PROXY STATEMENT

Company: PharmaCyte Biotech, Inc.
Filed: May 25, 2023
Period of Report: July 7, 2023
Accession Number: 0001683168-23-003706

View Document ↗ View on SEC.gov ↗